An Open-Label, Randomized, Single-Dose Study to Evaluate the Effects of 325 mg Ferrous Sulfate Tablet (65 mg Iron) on the Pharmacokinetics of 450 mg Dose of AKB-6548 in Healthy Male Volunteers.

Trial Profile

An Open-Label, Randomized, Single-Dose Study to Evaluate the Effects of 325 mg Ferrous Sulfate Tablet (65 mg Iron) on the Pharmacokinetics of 450 mg Dose of AKB-6548 in Healthy Male Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Apr 2015

At a glance

  • Drugs Vadadustat (Primary) ; Ferrous sulfate
  • Indications Anaemia
  • Focus Pharmacokinetics
  • Sponsors Akebia Therapeutics
  • Most Recent Events

    • 12 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
    • 03 Jan 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top